Douglas J. Swirsky
Chief Accounting Officer
Maxcyte, Inc. (MXCT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Douglas J. Swirsky
Douglas J. Swirsky is recorded as CFO and Chief Accounting Officer at Maxcyte, Inc. (MXCT). Maxcyte, Inc. reported in an 8-K filed March 28, 2023 that Douglas J. Swirsky was appointed principal accounting officer, effective March 27, 2023. Maxcyte, Inc. reported in an 8-K filed March 28, 2023 that Douglas J. Swirsky was appointed Chief Financial Officer, effective March 27, 2023.
“Mr. Swirsky will also serve as the Company’s principal accounting officer.”
“On March 27, 2023, the Board of Directors (the “Board”) of MaxCyte, Inc. (the “Company”) appointed Douglas J. Swirsky as the Company’s Chief Financial Officer, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-03-27–present
-
Current
2023-03-27–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Maxcyte, Inc.
Other people whose current roles at this company are on record from its filings.
- Maher Masoud CEO, Board Member
- Parmeet Ahuja CFO, Chief Accounting Officer
- David Sandoval General Counsel
- Ron Holtz Chief Accounting Officer
- Art Mandell Board Member
- Cynthia Collins Board Member
- John Johnston Board Member
- Patrick J. Balthrop Board Member
- Patrick J. Balthrop, Sr. Board Member
- Rekha Hemrajani Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.